Thyroid carcinoma metastatic to the maxillofacial area is extremely rare. Other carcinomas can metastasize to this area, but very few cases of follicular thyroid carcinoma metastasizing to the nasopharynx have been reported. Carcinoma from the kidney, liver, large bowel, prostate, and thyroid are known to have the potential for clear cell differentiation, and all of them can metastasize to the sinonasal area. Histochemical and immunohistochemical evaluations, along with clinical details, are useful in distinguishing metastases of these clear cell tumors from primary sinonasal tumors. In this article we describe a rare case of metastatic thyroid carcinoma with clear cell change mimicking metastatic renal cell carcinoma in the nasopharynx.
Introduction
Metastasis of malignant tumors to the paranasal sinuses is extremely rare and accounts for only 3% of sinonasal adenocarcinomas. 1 Metastasis of any tumor to the maxillofacial area is rare, but well-documented cases are on record. For example, Hirshberg et al, in a study of 390 cases of metastatic tumors to the jawbones, found that in women, tumors metastasizing to the jawbones spread most frequently from the breast, followed by the adrenal glands, colorectum, genital organs, and thyroid; in men, tumors spread most frequently from the lung, followed by the prostate, kidney, bone, and adrenal glands. 2 These researchers found that the most common location of the metastatic tumors in the jawbones was the mandible, with the molar area the most frequent site involved. 2 Although carcinomas from the prostate, lung, cervix, colon, and testes can metastasize to the head and neck region, 2-5 very few cases of follicular carcinoma of the thyroid metastasizing to the nasopharynx have been reported. Thyroid carcinomas are uncommon malignancies, accounting for about 2% of all new cancer cases. 6 Follicular carcinomas comprise approximately 5% of thyroid cancers; however, in iodine-deficient areas, this tumor is more prevalent, making up 25 to 40% of thyroid cancers. 7 Metastases of thyroid follicular carcinomas are usually blood-borne and usually spread to lung and bones rather than to regional nodes. 8 In this article we discuss a case involving a patient who presented with nasal stuffiness and painful deglutition caused by the metastasis of a follicular thyroid carcinoma to the sinonasal area.
Case report
A 52-year-old Indian woman presented with pus and watery discharge from her nose and nasal stuffiness of 1 month's duration. She also complained of painful deglutition. The patient had a history of a near-total thyroidectomy for follicular carcinoma of the thyroid at the age of 46 years. Slides or reports for her case were not available for review at our hospital.
Findings on x-rays of the chest and paranasal sinuses were normal. A neurologic evaluation was unremarkable, but a computed tomography scan of the brain and paranasal sinuses suggested a malignant skull base/ Volume 91, Number 12 www.entjournal.com  E17 NasopharyNgeal metastasis of follicular carciNoma of the thyroid with exteNsive clear cell chaNge: a case report nasopharyngeal mass with bone erosion and cerebral metastases.
Tru-Cut biopsies from the hard palate and nasal area were done. Histopathologic examination revealed clear cells arranged in cords and in a sinusoidal and pseudoglandular pattern separated by thin-walled blood vessels with areas of hemorrhage (figure 1). The tumor was submucosal. On higher magnification, the cells were medium to large in size, with a low nucleus-to-cytoplasm ratio and abundant clear cytoplasm. The nuclei were small, round to oval, and mildly hyperchromatic with few atypical mitoses. No colloid or colloid-like material was seen.
In view of clear cell morphology, histochemical stains were performed with periodic acid-Schiff (PAS), PAS with diastase, Alcian blue, and mucicarmine. Fat stain was not possible because the entire tissue was fixed to formalin. All the histochemical stains were negative.
Immunohistochemistry was performed with cytokeratin (CK), CK AE1, S-100 antigen, vimentin, CD10, EMA (epithelial membrane antigen), and actin for definite typing of a clear cell tumor, such as metastatic renal cell carcinoma (RCC), or a minor salivary gland neoplasm, such as clear cell carcinoma-not otherwise specified type (CCC-NOS) or clear cell myoepithelioma.
All markers were negative except CK, which was focally positive. This ruled out RCC and CCC-NOS of a minor salivary gland. Later, thyroglobulin and calcitonin were added to the immunohistochemistry testing because the patient had a history of thyroid surgery. Thyroglobulin was positive in all tumor cells, and calcitonin was negative (figure 2).
The patient was examined again, and fine-needle as-piration (FNA) of the thyroid swelling was performed.
The FNA showed a follicular neoplasm consistent with a recurrence of follicular carcinoma ( figure 3 ).
Discussion
Metastatic tumors to the sinonasal tract are extremely rare. They may present with epistaxis, pain, or nasal obstruction. In 1966, Bernstein et al reviewed 82 cases with metastatic foci to the paranasal sinuses, in which 40 patients had lesions in the maxilla, 15 in the ethmoids, 12 in the frontal sinuses, and 6 in the sphenoid sinuses; other sites included the nose, nasopharynx, palate, and alveolar ridge. 9 The overwhelming majority of primary tumors were from kidney (55%), followed by the bronchus and urogenital ridge (11% each), breast (10%), GI tract (6%), and thyroid (3%). In 1979, Barrs et al reported on a series of 8 patients with metastases to the paranasal sinuses; 2 patients had prostatic carcinomas as their primary tumors, 2 had myeloma, and 1 each had kidney, lung, breast, and follicular carcinoma of the thyroid. 10 RCC is the single most common sinonasal metastatic tumor, comprising 54%. 9 Our patient presented with a tumor with clear cell change in the sinonasal region. Surgical pathologists frequently encounter malignant neoplasms composed of clear cells, the source and nature of which cannot be determined on the basis of conventional morphologic study. In this context, many of these tumors with completely dissimilar lineage can show a strikingly similar microscopic appearance.
In our case, the tumor showed hemorrhage into the stroma and within the tubular epithelium. The possibility of RCC was considered, but vimentin and CD10 negativity ruled it out. A clear cell tumor of a minor salivary gland, particularly CCC-NOS, was another possibility, although this tumor is rare. These tumors show positivity for both epithelial and myoepithelial markers, such as vimentin, S-100, and actin. In our case all mesenchymal markers were negative, so tumors of a minor salivary gland were also ruled out.
Thyroid carcinomas are a heterogeneous group of tumors that demonstrate considerable variability in biologic behavior, histologic appearance, and response to therapy. In follicular carcinoma of the thyroid, metastases are usually blood-borne, particularly to lung and bones. The skeletal metastases are usually multicentric but have a predilection for the shoulder girdle, sternum, skull, and ileac bone. 11, 12 Metastatic tumors to the sinonasal tract are extremely rare. In a study of 224 sinonasal adenocarcinomas, only 7 (3%) were metastatic. 1 In 1997, Altman et al presented a case report and extensive review of the literature that revealed 11 prior reports of thyroid carcinoma metastatic to the paranasal sinuses, including 5 from the European literature. 13 In our case, the patient had a history of thyroid surgery. FNA cytology from an enlarged thyroid gland and immunohistochemistry results were suggestive of follicular carcinoma of the thyroid metastatic to the nasopharynx.
In conclusion, although sinonasal metastasis of a follicular carcinoma of the thyroid is very rare, the proper diagnosis can be reached with the help of immunohistochemistry, a detailed clinical history, and the physical examination.
Several tumors featuring clear cells can occur in the maxillofacial area. A correct diagnosis can usually be made using strict morphologic criteria with the help of a limited number of ancillary techniques. Still, proper identification of clear cell tumors typically requires close communication among physicians to procure salient clinical and radiographic details. Consideration of the application of adjuvant studies, together with fastidious integration of clinicoradiologic information, is a standard approach that can be applied for pathologic evaluation of any clear cell tumors. 
